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and Charles Zelwer
Background:  Phosphatidylethanolamine-binding protein (PEBP) is a basic
protein found in numerous tissues from a wide range of species. The screening
of gene and protein data banks defines a family of PEBP-related proteins that
are present in a variety of organisms, including Drosophila and inferior
eukaryotes. PEBP binds to phosphatidylethanolamine and nucleotides in vitro,
but its biological function in vivo is not yet known. The expression of PEBP and
related proteins seems to be correlated with development and cell
morphogenesis, however. To obtain new insights into the PEBP family and its
potential functions, we initiated a crystallographic study of bovine brain PEPB.
Results:  The X-ray crystal structure of bovine brain PEBP has been solved
using multiple isomorphous replacement methods, and refined to 1.84Å
resolution. The structure displays a β fold and exhibits one nonprolyl cis
peptide bond. Analysis of cavities within the structure and sequence
alignments were used to identify a putative ligand-binding site. This binding site
is defined by residues of the C-terminal helix and the residues His85, Asp69,
Gly109 and Tyr119. This site also corresponds to the binding site of
phosphorylethanolamine, the polar head group of phosphatidylethanolamine.
Conclusions:  This study shows that PEBP is not related to the G-protein
family nor to known lipid-binding proteins, and therefore defines a novel
structural family of phospholipid-binding proteins. The PEBP structure contains
no internal hydrophobic pocket, as described for lipocalins or small
phospholipid-transfer proteins. Nevertheless, in PEBP, a small cavity close to
the protein surface has a high affinity for anions, such as phosphate and
acetate, and also phosphorylethanolamine. We suggest that this cavity
corresponds to the binding site of the polar head group of
phosphatidylethanolamine.
Introduction
In 1984, Bernier and Jollès purified a soluble basic protein
with a significant affinity for organic anions from bovine
brain [1]. As affinity experiments showed that this protein
could interact in vitro with phosphatidylethanolamine, a
component of cell membranes, it was called phos-
phatidylethanolamine-binding protein (PEBP) [2]. In
addition, it was demonstrated that the bovine PEBP could
bind mononucleotides and dinucleotides (mainly GTP) in
vitro [3]. Homologous PEBPs were subsequently identi-
fied in numerous tissues from mammalian species [4]:
human (liver [5] and brain [6,7]), monkey (epididymis and
testis [8]) and rat (brain [9], epididymis and testis [8]).
PEBP was characterized as a single polypeptide chain of
186 or 187 amino acids with a molecular weight of about
21 kDa [10]. Comparisons with other primary sequences
did not reveal any significant identity with proteins of
known three-dimensional structure, suggesting that PEBP
might represent a novel protein family [10]. More
recently, the screening of gene and protein data banks
identified a family of proteins related to PEBP. Members
of this family include a potential odorant-binding protein
(OBP) found in the antenna of Drosophila [11], Ag16, an
antigen recognized by immune sera from patients infected
by the parasite Onchocerca volvulus [12], TES-26, a
secreted antigen of infective larvae of the ascaride nema-
tode parasite Toxocara canis [13], TFS1, a suppressor of
CDC25 mutations in Saccharomyces cerevisiae [14], Antir-
rhinum CEN, a protein involved in inflorescence develop-
ment [15] and a putative PEBP from Plasmodium
falciparum [16]. Thus, the PEBP-related proteins seem to
constitute a new widespread protein family. Apart from
the affinity of mammalian PEBPs for nucleotides and
phospholipids, little information is available concerning
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the accurate physiological function of the PEBP family;
however, it seems to be correlated with tissue develop-
ment and cellular morphogenesis. Indeed, PEBP is
encountered in oligodendrocytes of developing rat brains
and in elongated spermatides during rat spermatogenesis
[8,9]. Similarly, TFS1 seems to be involved in yeast
growth [14], and recessive mutations in the CEN gene
result in the conversion of the normal indeterminate inflo-
rescence to a determinate inflorescence in Antirrhinum
[15]. Until now, however, no structural experimental data
were available for this protein family, apart from a pre-
dicted model of PEBP based on weak primary and sec-
ondary structure similarities between bovine brain PEBP
and the N-terminal domain of yeast phosphoglycerate
kinase [17]. This work suggested that PEBP had a poten-
tial nucleotide-binding site with a Rossmann-fold topol-
ogy [18]. To obtain new insights into the PEBP family and
its potential functions, we initiated a crystallographic
study of bovine brain PEBP.
In this paper, we report the first crystal structure of a
member of the PEBP family at 1.8 Å resolution. This
work shows that bovine brain PEBP constitutes a novel
class of phospholipid-binding protein. In addition, the
X-ray structure of a PEBP–phosphorylethanolamine
complex at 2.25 Å resolution is presented, allowing a puta-
tive phospholipid-binding site to be defined. The binding
of GTP and the hypothetical biological function of PEBP
are also discussed.
Results
Bovine brain PEBP was crystallized in both monoclinic
and orthorhombic forms. The Cα atom superimposition of
both crystal form models led to low root mean square
(rms) deviations (0.438 Å and 0.506 Å for each monomer,
given by the LSQ option of the program O [19]), indicat-
ing no major differences between the two structures. In
light of this, and because the structure solved from the
monoclinic crystal was refined to a higher resolution, we
will focus mainly on the monoclinic crystal structure.
Quality of the atomic model
The final atomic model consists of 1466 nonhydrogen
atoms, 247 water molecules and one well-ordered mol-
ecule of acetate buffer (reported as ACT in the PDB coor-
dinates file). The PEBP model includes residues 1–185 of
the polypeptide chain; the C-terminal Lys186 is the only
residue not defined by the electron-density map. The
stereochemistry of the model was checked with
PROCHECK [20] and shows no disagreement with the
general stereochemistry rules. Of the total number of
residues, 92.7% are found in the most favored regions of
the Ramachandran plot and 7.3% in the additional allowed
regions. The structure reveals two cis peptide bonds:
between Ala72 and Pro73, and between Arg81 and Glu82.
Observed rms deviations from ideal values of bond
lengths and bond angles are 0.011 Å and 2.182°, respec-
tively. The overall coordinate error is estimated between
0.12 and 0.15 Å from a Luzzati plot. The mean atomic
temperature factor for the whole model is 12.0 Å2, includ-
ing solvent molecules.
General fold
The PEBP structure is made up of one unique domain
and has a β fold (Figure 1). This domain is formed by two
antiparallel β sheets having a Greek-key topology, and a
C-terminal αβα element. Both β sheets interact with each
other through a hydrophobic interface. The structure is
also characterized by long loops connecting the different
secondary structure elements. The PEBP model is rich in
β-turn structures and exhibits three short 310 helical
regions (residues 5–7, 13–15 and 96–99). PEBP secondary
structures were assessed according to DSSP convention
[21] (see Figure 1 legend). Comparison with known
protein structures (using the program DALI [22]) did not
reveal any folds from other protein structures that would
superimpose well. The best score was 4.3 for the Rho
GDP-dissociation inhibitor (RhoGDI; PDB code 1gdh)
which has a distinct β fold [23].
The cis peptide bonds
Both cis peptide bonds of PEPB are located after a β turn
(residues 69–72) in the loop connecting β strand S5 to
β strand S6. The cis Pro73 is located at the top of the loop
interacting with the sidechain atom Nε2 of His117
(Figure 2a). The nonprolyl cis peptide bond, between
Arg81 and Glu82, occurs between a β turn (residues
78–81) and the N-terminal extremity of β strand S6
(Figure 2a). Because of this configuration, two Cα atoms
of Arg81 and Glu82 are positioned within 3.0 Å of each
other (Figure 2b). Figure 2c also shows that the peptide
bond between Arg81 and Glu82 is not planar; this is due to
the backbone amide group of Glu82, which is 0.19 Å
above the plane defined by the peptide bond atoms.
Arg81 and Glu82 are well stabilized in the structure. The
cis peptide bond atoms can form two hydrogen bonds: one
with the mainchain carbonyl of Phe148 (hydrogen-bond
distance NGlu82–OPhe148, 2.78 Å) and one with the
sidechain amine group of Lys147 (hydrogen-bond dis-
tance OGlu82–NζLys147, 2.86 Å) (Figure 2a). The sidechains
of Arg81 and Glu82 are also stabilized by numerous hydro-
gen bonds with neighboring residues (Figure 2a). Another
unusual feature is the close contacts of the Cβ atom of
Glu82 with the mainchain carbonyl of Phe148 (distance
3.05 Å) and with the sidechain Oγ1 atom of Thr68 (dis-
tance 3.14 Å), which contributes to constrain the Glu82
conformation. The omit map calculated around this cis
peptide bond is shown in Figure 2d.
The ligand-binding site
An accessibility calculation using the program VOIDOO
[24] shows that the PEBP structure is rather compact. A
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single cavity was detected; this cavity is narrow and
located close to the protein surface (Figure 3). The cavity
is formed by residues of the C-terminal helix (Leu179,
Tyr180 and Leu183) and two strand-connecting regions
of β sheet 2 (Asp69, Ala72, Trp83, His85, Val106, Gly109,
Pro110, Pro111, His117 and Tyr119; Figure 4). The
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Figure 1
The general architecture of bovine brain
PEBP. (a) A topology diagram of PEBP;
β strands are symbolized by arrows and
α helices by rectangles. Residues with 310
helicity are represented by bars. β Sheet 1 (in
magenta) is formed by four antiparallel
strands: S1 (residues 22–28), S2 (residues
31–33), S3 (residues 38–39) and S4
(residues 51–53). β Sheet 2 (in purple) is also
formed by four antiparallel strands: S5
(residues 62–69), S6 (residues 83–92), S7
(residues 100–103) and S8 (residues
117–125). β Sheet 2 is terminated by an αβα
extension (yellow) comprising helix H1
(residues 150–156), strand S9 (residues
164–170) and helix H2 (residues 176–183).
(b) Stereoview ribbon model of PEBP. The
bound acetate molecule is represented by
green spheres. Both Greek-key motifs are
colored in magenta and purple, as in (a); the
αβα unit is indicated in yellow. (c) Stereoview
Cα backbone trace of PEBP, every tenth
residue is labeled and the N and C termini are
indicated. (The figures were generated using
the programs RIBBONS, version 2.80 [50]
and MOLSCRIPT [51].)
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Figure 2
The nonprolyl cis peptide bond between
Arg81 and Glu82. (a) The hydrogen-bond
network around the nonprolyl cis peptide
bond. The short contacts between the Cβ
atom of Glu82 and the O atom of Phe148 or
Oγ1 of Thr68 are represented by solid lines.
Other hydrogen bonds are shown as dashed
lines. Carbon atoms are shown in white,
nitrogen atoms in black and oxygen atoms in
gray. For clarity, some sidechains were
omitted. (b) The short contact between the
Cα atoms of Arg81 and Glu82. (c) The
nonprolyl cis peptide bond is nonplanar; the
peptide bond plane is symbolized by a dashed
line. (d) The omit map around residues
81–85. The map was calculated with the
coefficients (mFobs–DFcalc) [52] between 32
and 1.84 Å resolution, after Arg81 and Glu82
were removed from the coordinate model and
a simulated-annealing cycle was carried out at
3000K. The electron-density map is
contoured at a 3σ level. (The figures were
generated using the program MOLSCRIPT
[51] and the electron-density was created
with the program O [19].) 
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strand-connecting regions are defined as CR1 (residues
68–85) and CR2 (residues 106–119). Electrostatic poten-
tial surface analysis using GRASP [25] highlights a strip of
basic residues close to this cavity (Arg75, Lys76, Lys79,
Arg81, Arg118, Lys147, Lys149, Arg154, Lys155 and
Lys156; Figure 3). Among these basic residues, Arg118 is
conserved among the different members of the PEBP
family and is involved in the formation of a salt bridge
with Asp71, another conserved residue. Both cis peptide
bonds of the structure are found in close proximity to this
cavity (Figures 3 and 4). In the three different crystal
structures obtained — in the presence of phosphate,
acetate or phosphorylethanolamine — an anion group
occupies this site. In the monoclinic crystals, we
modeled a molecule of acetate hydrogen bonded to the
amide group of Gly109 (hydrogen-bond distance 2.76 Å),
to the Nε2 of His85 (hydrogen-bond distance 2.98 Å) and
to water molecules (Figures 4 and 5a). The methyl 
group of the acetate molecule is surrounded by hydro-
phobic residues (Trp83, Val106, Tyr180 and Leu183). In 
the orthorhombic crystals, the Fourier difference
(mFobs–DFcalc)exp(φcalc) map calculated after a first
refinement cycle, for data between 15 and 2.4 Å, exhibits
a high peak in this putative binding site. The tetrahedral
shape of this residual density is compatible with the
binding of a phosphate group in the cavity. Modeling
indicates that this phosphate ion establishes hydrogen
bonds with the sidechains of residues Tyr119, His85,
Asp69 and the backbone amide group of Gly109
(Figure 5b). Superimposition of the orthorhombic and
monoclinic models shows that the acetate- and phos-
phate-binding sites overlap (Figures 4 and 5a,b). In
addition, these anions superimpose well with the
phosphorylethanolamine molecule in the structure of 
the PEBP–phosphorylethanolamine complex. Phospho-
rylethanolamine constitutes the polar head group of phos-
phatidylethanolamine and binds PEBP in two possible
ways (indicated as Pe1 and Pe2 in Figures 5c and 5d).
The major interaction, Pe1, shows that the phospholipid
polar head group establishes hydrogen bonds with His85,
Asp69, Gly109 and Tyr119, as described for the phos-
phate ion. Additional interactions occur between the
carbonyl group of Gly109 and the amine group of phos-
phorylethanolamine, and between the ligand ethyl group
and Trp83. The minor interaction, Pe2, involves hydro-
gen bonds with the phosphate group only.
Discussion
Affinity experiments have shown that PEBP is able to bind
phospholipids as well as GTP [3]. Nevertheless, the bovine
PEBP structure is neither related to the G protein family
[26] nor to known lipid-binding proteins [27–29]. PEPB has
a β fold formed by two Greek-key motifs, a motif
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Figure 4
The putative ligand-binding site. The
carboxylate and methyl groups of the bound
acetate molecule are represented in red and
green, respectively; the phosphate molecule is
colored in purple. Water molecules are
represented as small light green spheres and
the C-terminal α helix is depicted as a yellow
ribbon. The position of the phosphate group
was calculated after superimposition of the
monoclinic and orthorhombic coordinate
models using the LSQ option in the program
O [19]. (The figure was generated using the
program RIBBONS, version 2.80 [52].)
Figure 3
The electrostatic surface potential of PEBP. The bound
phosphorylethanolamine is shown in the cavity in ball-and-stick
representation. Regions of negative potential are shown in red; regions
of positive potential are in blue. The strip of basic residues is labeled in
yellow. CR1 and CR2 represent strand-connecting regions 1 and 2,
respectively. (The figure was created using the program GRASP [25].)
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Figure 5
The binding of PEBP to anion groups. 
(a) Stereoview depicting the binding of the
acetate molecule. Carbon atoms are shown in
white, nitrogen atoms in black and oxygen
atoms in gray; hydrogen bonds are shown as
dashed lines. (b) Stereoview of the phosphate
binding. In order to optimize hydrogen bonding,
the sidechain of His85 was flipped from its
position in the acetate-bound model. 
(c) Stereoview electron-density map calculated
around the phosphorylethanolamine molecule
(3mFo–2DFc) with data between 15 and 2.25
Å. The map is contoured at the 1σ level. The
two alternative phosphorylethanolamine-
binding modes are labeled Pe1 and Pe2. 
(d) Stereoview to illustrate
phosphorylethanolamine binding. (The figures
were generated using the program
MOLSCRIPT [51] and the electron-density
was created with the program O [19].)
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frequently described for immunoglobin superfamilies. The
PEBP structure reported here constitutes the first structure
of a novel class of proteins that can interact with both phos-
pholipids and GTP.
The ligand-binding site
The PEBP structure does not contain any internal
hydrophobic cavity, as described for Sec14 (a phos-
phatidylinositol-transfer protein from Saccharomyces cere-
visiae [27]), lipocalins [28] or small lipid-transfer proteins
from plants [29]. However, a small cavity close to the
protein surface, involving residues of the C-terminal
helix and two strand-connecting regions (CR1 and CR2)
of the second Greek key, seems to form the ligand-
binding site of PEBP. The volume of this putative
ligand-binding site is rather small and we speculate that,
if it corresponds to the phospholipid-binding site, only
the polar head group of the phospholipid would be rec-
ognized. This is in agreement with the binding of a
phosphorylethanolamine molecule in the PEBP–phos-
phorylethanolamine crystal structure.
The CR1 and CR2 regions are comprised of residues that
are conserved throughout the PEBP protein family
(Figure 6). Among these residues, six are invariant in all
the sequences (Pro70, Asp71, Pro73, His85, Gly115 and
Arg118). The variant residues could modulate the size and
shape of the binding site and induce different ligand
specificities for each of these proteins. This concerns
mainly residues at positions 72, 80, 83 and 119, which face
the binding site (Figure 4).
The CR1 region exhibits two cis peptide bonds, between
Ala72 and Pro73 and between Arg81 and Glu82, at the
boundaries of the ligand-binding site. Nonprolyl cis
peptide bonds are very rare in protein structures. In 1990,
only 0.05% of all peptide bonds listed in the Brookhaven
Protein Data Bank (PDB) [30] had a cis conformation and,
in general, they were located in regions concerned with
protein function [31]. In Vibrio harveiy luciferase, for
example, the nonprolyl cis peptide bond occurs in a bulge
and is responsible for creating a small cavity at the active
site [32]. Moreover, in the PEBP structure, the residues
Arg81 and Glu82 are located close to a strip of basic
residues that are conserved in all mammalian PEBPs
(Figure 3). These basic residues could interact through
electrostatic contacts with the negatively charged surface
of the membrane layer, as suggested for the
calcium/phospholipid-binding C2 domain of cytosolic
phospholipase A2 (cPLA2) [33]. Thus, the nonprolyl cis
peptide bond of PEBP would be located in an area of the
protein concerned with membrane binding. Another line
of evidence for this region of PEBP having a functional
role is provided by the existence of Arabidopsis natural
mutant plants [34], which develop a single terminal
flower instead of the normal indeterminate inflorescence.
These Arabidopsis mutants are affected in their CEN
homologous gene (CEN belongs to the PEBP-related
protein family) and the deduced amino acid sequence of
one of these natural mutants contains the mutation
Glu82→Lys.
On the issue of GTP binding, a model of PEBP predicted
on the basis of an alignment with phosphoglycerate
kinase, suggested that the consensus sequence of
residues 112–125 formed an α/β nucleotide-binding site
with Rossmann-fold topology [17]. In our crystal struc-
ture, residues 112–125 are indeed found close to the puta-
tive ligand-binding site, but they do not belong to a
Rossmann fold. Residues 112–125 include β strand S8
and a part of the CR2 region. However, the presence of a
phosphate (or a sulfate) ion is often a hallmark for a
nucleotide-binding site (e.g. the RNA-binding site of
ribonuclease [35] or the NADP+-binding site of ferre-
doxin NADP+ reductase [36]). Nevertheless, if this cavity
does correspond to the GTP-binding site, it seems too
narrow to accommodate a whole nucleotide molecule in
the absence of any conformational changes. GTP might
be recognized by its pyrophosphate group, which could fit
into the cavity and would be stabilized by hydrogen
bonds with residues His85, Asp69, His117, Gly109 and
Tyr119. The GTP pyrophosphate group might also be
recognized by the strip of basic residues through electro-
static interactions.
Hypothetical function
Comparison of the PEBP structure with other folds in the
PDB gives the highest score for the C-terminal domain of
a Rho GDP-dissociation inhibitor (RhoGDI), a protein
that negatively regulates Rho family GTPases [23]. This
protein has an immunoglobulin-like fold with a modified
Greek key β-strand topology. Indeed, the superimposition
of the β sheets of this structure and of PEBP is possible,
but the strand connectivity is different. In RhoGDI, the
two Greek keys are formed by noncontiguous segments in
the protein primary sequence. The same observation is
made with the Greek-key topology identified in the
calcium/phospholipid-binding domain of synaptotagmin I
[37], a synaptic vesicle membrane protein, and some
phospholipases (cPLA2 [33] and PLCδ1 [38]). The
calcium/phospholipid-binding site of these proteins is
formed by loops that resemble the PEBP CR1 and CR2
regions. Thus, PEBP could have a similar function and
may also be a membrane-binding protein, interacting with
other proteins and possibly modulating their catalytic
activities. Recently, it was reported that TSF1, a PEBP-
related protein, is a carboxypeptidase Y inhibitor, estab-
lishing that members of the PEBP family can interact with
other proteins [39].
In conclusion, our crystallographic study shows that
PEBP is neither related to the G protein family nor to
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known lipid-binding proteins, and that its structure
defines a novel family of phospholipid-binding proteins.
We identify a putative phospholipid-binding site, the
role of which has yet to be confirmed by biochemical
and mutagenesis experiments. Such experiments will be
conducted in parallel with further crystallographic
studies to determine the structures of PEBP in complex
with GTP and a complete phospholipid molecule.
However, understanding the in vivo function of this
protein and its related family, will require further inves-
tigations at the cellular level. For this purpose, the study
of mutants, designed with the help of our structure,
might help to isolate phenotypes linked to PEBP muta-
tions and will shed some light on the biological function
of the PEBP family members and their potential part-
ners in the cell.
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Structure
Sequence alignments. The figure shows an alignment of the amino
acid sequences of seven members of the PEBP family: bovine brain
PEBP [10], Onchocerca volvulus Ag16 [12], Drosophila OBP [11],
Toxocara canis TES-26 [13], Antirrhinum CEN [15], Saccharomyces
cerevisiae TFS1 [14], the ylr179c gene product of S. cerevisiae [53]
and Plasmodium falciparum PEBP [16]. Sequence homologies are
highlighted in red; sequence identities are shown as white letters on a
red background. Both of the cis peptide bonds are marked by green
triangles and His85 is indicated by a blue star. The secondary
structure elements of bovine brain PEBP have been added to the
figure (assigned according to DSSP): helices are displayed as
squiggles and β strands as arrows. TT is used to mark a β turn and η1,
η2 and η3 indicate the 310 helices. (The figure was created using
ESPrit [P Gouet and F Metoz, unpublished program]).
Biological implications
Phosphatidylethanolamine-binding protein (PEBP) is a
21 kDa basic protein that was first isolated from bovine
brain [1]. It was shown that, in vitro, PEBP binds to both
phosphatidylethanolamine and GTP [2,3]. Although its
precise biological role is still unknown, PEBP has been
detected in numerous mammalian tissues, including brain
cells, elongated spermatides from testis, placenta and liver
[5–9]. Thus, it seems that PEBP is present in cells exhibit-
ing morphogenesis activity. In addition, sequence align-
ments have shown that mammalian PEBP belongs to a
larger family of proteins that seem to be related to devel-
opmental processes. Members of this family include CEN
[15] (a protein involved in inflorescence architecture
control), antigens secreted by parasite larvae [13] and
TFS1, a suppressor of CDC25 mutation in yeast [14].
In order to obtain new insights into PEBP function, we
have solved the X-ray crystal structures of bovine brain
PEBP both on its own and in complex with phospho-
rylethanolamine (the polar head group of phos-
phatitylethanolamine). These structures show that
PEBP and PEBP-related proteins constitute a struc-
tural protein family that is unrelated to any G-protein
family members or to any lipid-binding proteins of
known structure. In addition, we have identified the
putative phospholipid-binding site of PEBP: a small
cavity located close to the protein surface and defined by
the residues His85, Asp69, Gly109 and Tyr119.
Although these structures do not yet indicate the precise
in vivo function of PEBP, they do show that PEBP
exhibits some similarities to other proteins: the C-termi-
nal domain of a Rho GDP-dissociation inhibitor, which
negatively regulates Rho family GTPases [23]; the
calcium/phospholipid-binding domains of synaptotagmin
I [37], a synaptic vesicle membrane protein; and some
phospholipases (cytosolic PLA2 [33] and PLCδ1 [38]).
On the basis of these homologies, we believe that PEBP
may have a similar function and might be a membrane-
binding protein, interacting with other proteins and
perhaps modulating their catalytic activities. The crys-
tallographic data presented here constitute a solid basis
to design genetic experiments that will help to provide
new insights into the biological function of PEBP and its
potential partners in the cell.
Materials and methods
Crystallization
PEBP was purified from bovine brain as previously described [1]. For
the crystallization, PEBP was concentrated to 5 mg/ml in 10 mM Hepes
buffer (pH 7.0) and 2 mM dithiothreitol (DTT). Two different crystal
forms were obtained using the hanging-drop method with the following
crystallization conditions: form I was prepared in 20–25% polyethylene
glycol 4000 (PEG 4000), 0.2 M ammonium acetate and 0.1 M acetate
buffer (pH 4.6); form II was prepared in 18–25% PEG 8000 and
50 mM KH2PO4. Under these conditions, crystals grew as bunches of
thin plates after three days (form I) and three weeks (form II). In order to
produce thicker single crystals and to accelerate crystal growth,
macroseeding in hanging drops was then used routinely. Form I crystals
are monoclinic and belong to space group C2 (unit-cell dimensions
a = 82.70 Å, b = 33.55 Å, c = 60.07 Å, β = 97.71° with one molecule
per asymmetric unit). Form II crystals are orthorhombic and belong to
space group P212121 (unit-cell dimensions a = 44.97 Å, b = 77.30 Å,
c = 108.17 Å, with two molecules per asymmetric unit).
As yet, we have not succeeded in cocrystallizing PEBP with its real
substrates, GTP or phosphatidylethanolamine, but it was possible to
grow crystals of PEBP complexed with the polar head group of phos-
phatidylethanolamine (phosphorylethanolamine). Crystals of PEBP in
complex with phosphorylethanolamine (form III) were obtained in
25–27% PEG 8000 and 100 mM phosphorylethanolamine. These
crystals are similar to form II. They are orthorhombic and belong to
space group P212121 (unit-cell dimensions a = 44.20 Å, b = 77.16 Å,
c = 107.48 Å, with two molecules per asymmetric unit).
Data collection and phasing
The PEBP crystal structure was solved from the monoclinic crystals
using the multiple isomorphous replacement (MIR) method with anom-
alous scattering. Crystals of two heavy-atom derivatives were charac-
terized at our laboratory with a MAR research imaging plate coupled to
a RIGAKU rotating anode with λ = 1.54 Å and at a temperature of
100K. The derivatives were prepared by soaking native crystals under
the following conditions: 5 mM HgCl2 (for 48 h) or 5 mM K2PtCN4 (for
24 h) in 25% PEG 4000, 0.2 M ammonium acetate, 0.1 M acetate
buffer pH 4.6. All the diffraction experiments were carried out at 100K.
Before flash freezing, crystals were quickly soaked in a solution con-
sisting of 25% PEG 4000, 15% glycerol, 0.1 M ammonium acetate
and 0.1 M acetate buffer, pH 4.6.
Higher resolution experiments were then conducted using synchro-
tron radiation (Beamline DW32, LURE, Orsay, France) with a MAR
research imaging plate system at λ = 0.97 Å and 100K. Further
details on data collection are presented in Table 1. The data were
integrated and reduced with MOSFLM, version 5.50 [40] and
SCALA [41]. Scaling between the different data sets and other cal-
culations were carried out using the CCP4 suite of programs [42].
Mercury sites were identified in isomorphous and anomalous differ-
ence Patterson maps for both synchrotron and rotating-anode data;
one platinum site was identified in an isomorphous difference Patter-
son map. Refinement of the heavy-atom sites, the phase calculation
and the phase refinement were done with SHARP [43] using both
synchrotron and rotating-anode data. The final phase calculation
resulted in a figure of merit of 0.65 for acentric reflections (0.68 for
centric reflections) for data between 32 and 2.6 Å resolution. The
phases were then improved by the density modification method
implemented in SOLOMON [44]. The best electron-density map was
obtained with data between 32 and 2.9 Å resolution. Model building
was carried out from this latter electron-density map using the
program O [19] installed on an SGI Indigo II graphic system.
Refinement
The initial crystallographic R factor and free R factor (calculated with
10% of the full data set excluded from the refinement process [45]) for
the model that included residues 1–184, and for all the reflections
between 8.0 and 1.84 Å resolution, were 52.5% and 51.2%, respec-
tively. These values dropped to 38.4% and 46.5% after one cycle of
simulated annealing carried out at 3000K with the program X-PLOR,
version 3.851 [46]. Further refinement steps were performed with
REFMAC [47] considering all the data between 32 and 1.84 Å resolu-
tion. Residue Gly185 and one acetate molecule were easily placed in
the resulting electron-density map. Water molecules were identified
automatically with ARP [48]. The crystallographic R factor and free
R factor decreased to 14.7% and 21.2%, respectively, after the last
refinement cycle for all the data between 32 and 1.84 Å resolution.
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Orthorhombic form and the PEBP–phosphorylethanolamine
complex
The final monomeric model was used to locate two PEBP monomers in
the orthorhombic crystal form by molecular replacement (AMoRe
program [49]). After rigid-body refinement, the structure-factor correla-
tion and the R factor for the best solution were 0.72 and 32.2%,
respectively, for data between 15.0 and 4.0 Å resolution. Residual
density allowed addition of the backbone atoms of the C-terminal
residue (Lys186) and one phosphate ion for each monomer. After one
cycle of simulated annealing, carried out at 3000K with X-PLOR
version 3.851 [46], further refinement steps with REFMAC [47] and
using noncrystallographic symmetry (NCS) restraints (tight restraints
in the first steps then loosened restraints were used in the last refine-
ment cycle), led to an R factor and a free R factor of 20.7% and
31.5%, respectively, for all the reflections between 12.5 and 2.4 Å
resolution. Water molecules (149) were identified automatically with
ARP [48]. The structure of the PEBP–phosphorylethanolamine
complex was solved independently by molecular replacement with the
monoclinic model and refined using the same procedure as described
for the orthorhombic form. The final model includes two PEBP
monomers, two phosphorylethanolamine molecules and 163 water
molecules. The crystallographic R factor and free R factor are 21.0%
and 28.1% for data between 12.5 and 2.25 Å. The data collection
statistics are summarized in Table 1.
Accession numbers
The atomic coordinates of the bovine brain PEPB (form I) have been
deposited in the Brookhaven PDB with accession code 1a44.
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